Wei Li
About Wei Li
Wei Li is a Senior Manager in Biostatistics at Bristol Myers Squibb with expertise in oncology biostatistics and a strong background in clinical trials and statistical programming.
Current Role at Bristol Myers Squibb
Wei Li has been serving as the Senior Manager of Biostatistics at Bristol Myers Squibb in Lawrenceville, NJ, since October 2019. In this role, Li applies his expertise in oncology biostatistics within the Market Access team. His responsibilities likely include overseeing the design, implementation, and analysis of clinical trials, ensuring compliance with industry standards such as eCRFs, cDISC-compliant SDTM, ADaM, and TLFs.
Previous Experience at EDETEK, Inc.
From 2017 to 2019, Wei Li worked as a Senior Biostatistician at EDETEK, Inc. in Princeton, NJ. In this role, Li was instrumental in transforming data into actionable assets, leveraging his strong background in clinical trials and statistical programming. His work likely involved ensuring data integrity, compliance with regulatory standards, and addressing complex biostatistical challenges.
Educational Background
Wei Li has a diverse and comprehensive educational background. He achieved an MS in Financial Engineering from Columbia Engineering in 2005. Prior to that, he earned an MS in Biostatistics from Columbia University in 2001 and an MS in Oral Biology from the University of California, Los Angeles, in 1999. His academic journey began with a BS in Biochemistry from Peking University, completed in 1997. This extensive education has provided Li with a strong foundation in both biostatistics and financial engineering.
Experience at Columbia University and New York State Psychiatric Institute
Wei Li worked at Columbia University Department of Psychiatry and the New York State Psychiatric Institute from 1999 to 2005. In these roles, he served as a Biostatistician and Project Manager. During his tenure, Li was likely involved in various research projects, contributing to statistical analyses and project management tasks that supported psychiatric research and clinical trials.
Expertise in Clinical Trials and Statistical Programming
Wei Li possesses a robust expertise in clinical trials, electronic case report forms (eCRFs), and adherence to Clinical Data Interchange Standards Consortium (cDISC) guidelines, specifically with SDTM, ADaM, and TLFs. His advanced skills in statistical programming enable him to handle complex datasets and generate reliable and meaningful insights that support clinical and market access strategies.